Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.

Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.

Item
http://www.wikidata.org/entity/Q33331583
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancerNovel treatments and therapies in development for pancreatic cancer.The pemetrexed/gemcitabine combination in pancreatic cancer.Recent developments in the pharmacological treatment of advanced pancreatic cancer.Developments in metastatic pancreatic cancer: is gemcitabine still the standard?Emerging drugs in pancreatic cancer.Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in BXPC-3 and PANC-1 human pancreatic cancer cells.Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent.A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancerSingle-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions.
P2860

Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.

Item
http://www.wikidata.org/entity/Q33331583
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Phase II study of the multitar ...... th advanced pancreatic cancer.
@ast
Phase II study of the multitar ...... th advanced pancreatic cancer.
@en
Phase II study of the multitar ...... th advanced pancreatic cancer.
@nl
type
label
Phase II study of the multitar ...... th advanced pancreatic cancer.
@ast
Phase II study of the multitar ...... th advanced pancreatic cancer.
@en
Phase II study of the multitar ...... th advanced pancreatic cancer.
@nl
prefLabel
Phase II study of the multitar ...... th advanced pancreatic cancer.
@ast
Phase II study of the multitar ...... th advanced pancreatic cancer.
@en
Phase II study of the multitar ...... th advanced pancreatic cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Phase II study of the multitar ...... th advanced pancreatic cancer.
@en
P2093
P304
P31
P356
P433
P478
P577
P698